Redefining the Classifications of Response to Cardiac Resynchronization Therapy: Results From the REVERSE Study - JCEP July 2021

Cardiac resynchronization therapy (CRT) improves functional status and outcomes in selected populations with heart failure (HF). However, approximately 30% of patients do not improve with CRT by various metrics, and they are traditionally classified as nonresponders. This study sought to assess the impact of a more detailed classification of response on survival.

Editor-in-Chief

Kalyanam Shivkumar, MD, PhD, FACC

CME Editor
Kenneth A. Ellenbogen, MD

Author
Kenneth A. Ellenbogen, MD

Important Dates
Date of Release: July 19, 2021
Term of Approval/Date of CME/MOC/ECME Expiration: July 18, 2022

Summary


Availability:	On-Demand
	Expires on Jul 18, 2022


Cost:	FREE

Credit Offered:

1 CME Credit

1 ABIM-MOC Point

1 ECME Credit